Evidence map›Paper›PMID 39367660›Full record

ArticleClinical and translational medicine2024

Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction-associated fatty liver disease.

Minji Lee, Myung Jin Son, Sin-Hyoung Hong, Jae-Sung Ryu, Ji-Hyeon Min, Dong-Eon Lee, Ji Hoon Lee, Nam Doo Kim, Shi-Young Park, Darong Kim and 9 more

Abstract readLetter
In one paragraph

Article in Clinical and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Minji Lee *Digital Omics Research Center, Korea Basic Science Institute (KBSI), Cheongju, Republic of Korea.
Myung Jin Son *Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.
Sin-Hyoung Hong *Digital Omics Research Center, Korea Basic Science Institute (KBSI), Cheongju, Republic of Korea.
Jae-Sung RyuNew Drug Development Center, Osong Medical Innovation Foundation, Cheongju, Republic of Korea.
Ji-Hyeon MinDigital Omics Research Center, Korea Basic Science Institute (KBSI), Cheongju, Republic of Korea.
Dong-Eon LeeDigital Omics Research Center, Korea Basic Science Institute (KBSI), Cheongju, Republic of Korea.
Ji Hoon LeeNew Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea.
Nam Doo KimNew Drug Discovery & Development, VORONOIBIO Inc., Incheon, Republic of Korea.
Shi-Young ParkKorea Mouse Metabolic Phenotyping Center, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, South Korea.
Darong KimNew Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea.
Jeongmin JooNew Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea.
Jisung KwakSensor System Research Center, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.
Kook Hwan KimDiscovery Division, GI Innovation, Inc., Seoul, South Korea.ORCID 0000-0003-0360-4435
Yong-Ho LeeDepartment of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Byeong-Rak KeumDepartment of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea.
Hyun Seok SongSensor System Research Center, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.
Youngae JungIntegrated Metabolomics Research Group, Metropolitan Seoul Center, Korea Basic Science Institute (KBSI), Seoul, Republic of Korea.
Koon Soon KimDivision of Endocrinology and Metabolism, Daejeon Endo Internal Medicine, Daejeon, Republic of Korea.
Gun-Hwa KimDigital Omics Research Center, Korea Basic Science Institute (KBSI), Cheongju, Republic of Korea.

Funding

Korea Basic Science Institute Grant number C270300National Research Foundation of Korea Grant number NRF-2021R1A2C1008663
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Non-alcoholic Fatty Liver DiseaseAnimalsCytochrome P-450 Enzyme InhibitorsHumansMetabolic DiseasesCytochrome P-450 Enzyme Inhibitors

Identifiers

PMID39367660
PMCPMC11452733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.